NOVOLOG PACKAGE INSERT EPUB

16 Mar Dosage Adjustment Due to Drug Interactions NOVOLOG® (insulin aspart injection) solution for Step Insert the needle into. Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Novolog (insulin aspart). Learn about NovoLog® mealtime insulin, a man-made rapid-acting insulin for adults and children with diabetes. Read important safety & prescribing info on this.

Author: Akikus Brashicage
Country: Bahrain
Language: English (Spanish)
Genre: Politics
Published (Last): 6 September 2005
Pages: 33
PDF File Size: 10.5 Mb
ePub File Size: 3.61 Mb
ISBN: 812-2-96971-200-7
Downloads: 87580
Price: Free* [*Free Regsitration Required]
Uploader: Bamuro

Curr Med Res Opin. Your insulin dose may need to change because of: Does not include Medicaid. Look up your patients’ formulary coverage.

Other common side effects may include: Malfunction of the insulin pump or insulin infusion set or insulin degradation can rapidly lead to hyperglycemia novolog package insert ketoacidosis.

A randomized, open-label, crossover study in subjects with diabetes. Eat a meal within 5 to 10 minutes after taking it. If you need assistance with prescription costs, help may novolog package insert available.

You are encouraged to report jnsert side effects of prescription drugs to the FDA. The first and only pen with a memory function and half-unit dosing.

The timing novolog package insert hypoglycemia may reflect the time-action profile of the insulin formulation. Important Limitations of Use. Get insights from experts.

Check your blood sugar levels. Monitor potassium levels in patients at risk for hypokalemia and treat if indicated. Novolog package insert in Specific Populations. Know the type and strength of your insulin. onvolog

Novolog package insert heart failure occurs, dosage reduction or discontinuation of the TZD must be considered. Thought leaders talk about bolus insulin therapy, from the role of PPG control in helping to reach A1C goals to improving patient engagement.

Serious side effects can lead to death, including: These changes should be made cautiously under close medical supervision and the frequency of blood glucose monitoring should be increased. Dosed within 15 minutes before or after starting a meal in patients with type 2 diabetes, unlike the required 30 minutes before meals with human premix insulin novolog package insert.

NovoLog® Rapid-Acting Insulin | NovoLog® (insulin aspart injection) U/mL

Sharing poses a risk for transmission of blood-borne novolog package insert. Ask your health care provider what your blood sugar levels should be and when you should check them. Similar co-pay as human premix insulin on most managed care plans a. Selected Important Safety Information.

NovoLog® Instructions For Use

Intended as a guide. Monitor potassium levels in patients at risk for hypokalemia and treat if indicated. Learn about another mealtime insulin option from Novo Nordisk. Patients should be observed novolog package insert signs and symptoms of heart failure.

Changes in insulin strength, manufacturer, type, or method of novolog package insert may pakcage glycemic control and predispose to hypoglycemia or hyperglycemia. Glucose monitoring is recommended for all patients with diabetes and is particularly important for patients using external pump infusion therapy.

Use in Specific Populations. If heart failure occurs, dosage reduction or discontinuation of the TZD must be considered.

FDA Internet Application Site (Accessdata) Error

Continue with your regular dosing schedule at the next meal. Talk to your doctor about which option may be best for you.

Selected Important Safety Information. Novolo emergency medical help if you have: Changes pacjage insulin strength, manufacturer, type, or method of administration may affect glycemic control and predispose to hypoglycemia or hyperglycemia.

The proportions of rapid-acting and long-acting novolog package insert are fixed and do not allow for basal versus prandial dose adjustments. Patients using insulin infusion pump therapy must be trained to administer insulin by injection and have alternate insulin therapy available in case of pump failure.

Hypoglycemia is the most common adverse effect of insulin therapy.